Market Cap

Lavipharm SA Market Capitalization:

€166.5 Million

EUR as of Jan. 1, 2026

US$195.5 Million

business Lavipharm SA Company Profile

Lavipharm SA Main Stock Listing

ASE: LAVI

Market Capitalization History of Lavipharm SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
AstraZeneca $284.38 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Lavipharm SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €166.5 M 16.12%
Jan. 1, 2025 €143.4 M 8.40%
Jan. 1, 2024 €132.3 M 1558.57%
Jan. 1, 2023 €8.0 M -39.02%
Jan. 1, 2022 €13.1 M 328.14%
Jan. 1, 2018 €3.1 M 89.77%
Jan. 1, 2017 €1.6 M -24.79%
Jan. 1, 2016 €2.1 M -1.68%
Jan. 1, 2015 €2.2 M -15.00%
Jan. 1, 2014 €2.6 M -30.00%
Jan. 1, 2013 €3.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Lavipharm SA Categories

languages Healthcare languages Drug Manufacturers—General

Stocks & Indices

Lavipharm SA has the following listings and related stock indices.


Stock: ASE: LAVI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.